10:17 AM EST - Knight Therapeutics Inc. : Today reported financial results for its third quarter ended September 30, 2024. The company delivered revenues of $92,263, an increase of $10,763 or 13% or $13,801 or 18% on a constant currency basis, over the same period in the prior year. Gross margin of $45,017 or 49% of revenues compared to $40,182 or 49% of revenues in the same period in the prior year. Adjusted EBITDA was $13,454, a decrease of $2,058 or 13% over the same period in the prior year. Knight Therapeutics Inc.
shares T.GUD are trading down $0.35 at $5.39.
